About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72722 record(s)
Req # A-2020-000448
Adverse Reaction Report (AER). Report number: E2B_03099852.Organization: Health Canada
November 2020
Req # A-2020-000461
Adverse Reaction Report (AER) for Pms-Epirubicin. Report number: E2B_02763034.Organization: Health Canada
November 2020
Req # A-2020-000467
Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03026017.Organization: Health Canada
November 2020
Req # A-2020-000476
Adverse Reaction Reports (AERs). Report numbers: 000732496, E2B_02595998, E2B_03063320, E2B_02994441.Organization: Health Canada
November 2020
Req # A-2020-000502
Adverse Reaction Reports (AERs) for Dexamethasone. Report numbers: E2B_02615079, E2B_02615949, E2B_02622626, E2B_02624834, E2B_02629779, E2B_02637390, E2B_02646722, E2B_02647594, E2B_02648440, E2B_02659246, E2B_02695461, E2B_02699192, E2B_02725456,…Organization: Health Canada
November 2020
Req # A-2020-000503
Adverse Reaction Reports (AERs) for Dexamethasone. Report numbers: E2B_02438885, E2B_02465960, E2B_02696143, E2B_02753981, E2B_02476806, E2B_02664075.Organization: Health Canada
November 2020
Req # A-2020-000517
Adverse Reaction Report (AER) for CEFIXIME. Report number: E2B_02868430.Organization: Health Canada
November 2020
Req # A-2020-000524
Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_01319957, E2B_02957403, E2B_01545734, E2B_02959466, E2B_02893387, 736281, 736290, E2B_02949034, E2B_02951434, E2B_02894317, E2B_02908946, E2B_02431950.Organization: Health Canada
November 2020
Req # A-2020-000525
Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: 731475, 734190, 735227, E2B_02845865, E2B_02891064, E2B_02952155.Organization: Health Canada
November 2020
Req # A-2020-000526
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_01013132.Organization: Health Canada
November 2020